Effectiveness evaluation of hemibody irradiation as palliative treatment of patients with multiple painful bone dissemination
Journal Title: Współczesna Onkologia - Year 2005, Vol 9, Issue 5
Abstract
Effectiveness of hemibody irradiation (HBI) of 61 patients with multiple painful bone dissemination treated between 2001-2004 was evaluated. 21 patients had UHBI and 40 LHBI. Pain intensity on an 11-degree scale, pain frequency on a 4-degree scale and the kind of analgesics used were evaluated. Patients were examined on HBI day, 2 weeks later and next, every month. Dependencies between pain before HBI and pain relief 2 and 6 weeks later were checked. Pain 2 and 6 weeks after U and LHBI, and pain relief at that time for breast and prostate patients were compared. Mean pain intensity on HBI day was 6.3 and decreased to 3.0 after 2 weeks. Subsequent values were 4.0, 3.0, 3.0, 4.5, 2.0 and 3.4 six months later. Mean pain frequency on HBI day was 3.1 and did not change significantly (from 2.8 to 3.0). On HBI day 3.4% of patients did not use analgesics, 31% used NSAID, 8.6% tramadol, 10.3% opioids, 10.3% NSAID+tramadol and 36.2% NSAID+opioids, so 46.5% used opioids. A percentage of patients without analgesics increased to 37.5% and a percentage using opioids decreased to 25% 3.5 months later. Dependency between pain before HBI and pain relief 2 weeks later was found. Pain relief 2 and 6 weeks after HBI was higher for breast than for prostate patients. No difference between U and LHBI effectiveness was found. Obtained results allow us to conclude that HBI is an effective and simple treatment modality for patients with multiple painful skeletal dissemination allowing an analgesics intake to be decreased.
Authors and Affiliations
Leszek Miszczyk, Aleksandra Gaborek, Jerzy Wydymański
Keywords
Related Articles
- EP ID EP82293
- DOI -
- Views 61
- Downloads 0
Wyniki leczenia chorych na złośliwego międzybłoniaka opłucnej w materiale Centrum Onkologii w Krakowie
Celem pracy jest przedstawienie wyników leczenia chorych na złośliwego międzybłoniaka opłucnej w Centrum Onkologii w Krakowie. Materiał: W latach 1965–2003 w Centrum Onkologii w Krakowie leczono 63 chorych z powodu złoś...
Primary adenocarcinoma of the appendix: a case report
The aim of this work was to assess the dependence between concentration of histamine in serum and primary mammary gland cancer tissue and activity of histamine metabolism enzymes. The work concerned 95 women age 38-70, d...
HDR brachytherapy of skin cancer - the Wielkopolski Cancer Centre\'s experience
Purpose: To analyze treatment results of HDR brachytherapy (BT) in patients with skin tumors. Material and methods: 179 patients with skin tumor were treated with HDR BT in the Wielkopolski Cancer Center between May 199...
Współczesne leczenie raka skóry – dermatologia, chirurgia czy radioterapia?
Raki skóry są najczęściej występującymi nowotworami złośliwymi. Stanowią istotny problem kliniczny ze względu na częstość oraz poważne defekty kosmetyczne, które wywołują, gdy nie są leczone, pogarszając tym samym jakość...
Radiochemioterapia glejaka wielopostaciowego powikłana wielonarządową grzybicą kropidlakową – opis przypadku
Od niedawna standardem leczenia chorych na glejaka jest zabieg chirurgiczny z uzupełniającą radioterapią skojarzoną z podawaniem temozolomidu. W trakcie chemioradioterapii chorej na glejaka wystąpiła ostra niewydolność...